Mkts

Quince Therapeutics, Inc.

NASDAQ: QNCX
$37.36-2.44 (-6.13%)
As of Nov 15, 7:00 PM ET

Key statistics

Day range
35.0843.48
52-week range
15.10910.00
Today
Open43.07
Previous close37.36
Volume21.8K
Valuation
Market cap32.27M
P/E ratio—
EPS (TTM)-125.71
Income & risk
Dividend / yield—
Beta1.79
Avg volume48.6K
Discussion

QNCX News

Stories mentioning QNCX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development6,84512,6018,0836,5538,1455,8254,9164,147
Sales General & Admin
Total Operating Expenses14,59019,35313,43010,42714,85812,0125,86328,192
Operating Income (Loss)(14,590)(19,353)(13,430)(10,427)(14,858)(12,012)(5,863)(28,192)
Interest Income160.00227.00300.00311.00406.00536.00683.00823.00
Interest Expense
Other Expense1,719660.00(58.00)(29.00)(87.00)(518.00)150.0091.00
Pretax Income(14,983)
Tax Provision(5,339)3,146(46.00)67.0047.007.0013.0036.00
Net Income (Loss)35,912(39,458)(13,442)(16,049)(15,030)(12,458)(5,492)(27,729)
Earnings Per Share (Basic)3.60(0.79)(0.25)(0.34)(3.42)(0.29)(0.13)(0.64)
Earnings Per Share (Diluted)2.88(0.79)(0.25)(0.34)(3.42)(0.29)(0.13)(0.64)
Weighted Average Shares Outstanding (Basic)9,12050,09753,95146,6864,39443,26243,16443,096
Weighted Average Shares Outstanding (Diluted)9,19050,09753,95146,6864,39443,26243,16443,096

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About QNCX

Quince Therapeutics, Inc. (NASDAQ: QNCX) is a stock listed on the Nasdaq Stock Market under the ticker symbol QNCX. It last traded at $37.36 (Nov 15, 2026, 7:00 PM ET), down 6.1% on the day. That gives Quince Therapeutics a market capitalisation of $32.3M.

Over the past 52 weeks QNCX has traded between $15.10 and $910.00.

Net income for the quarter ended Mar 31, 2026 was $35.9M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—$35.9M
Dec 31, 2025—-$39.5M
Sep 30, 2025—-$13.4M
Jun 30, 2025—-$16.0M

From Quince Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…